4
Changes in Ownership
BIO-TECHNE Corp Filed Acc 0001437749-21-027339
Pres. Diagnostics & Genom sold 500 shares at an average $505.38 ($252,689)
- Pres. Diagnostics & Genom acquired 500 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Kelderman Kim Pres. Diagnostics & Genom | 2021-11-19 | Option exercise | +500 | $150.78 | $75,390 | 500 | D |
| Kelderman Kim Pres. Diagnostics & Genom | 2021-11-19 | Sale | −100 | $503.76 | $50,376 | 400 | D |
| Kelderman Kim Pres. Diagnostics & Genom | 2021-11-19 | Sale | −400 | $505.78 | $202,313 | 0 | D |
| Derivatives | |||||||
| Kelderman Kim Pres. Diagnostics & Genom | 2021-11-19 | Option exercise · Stock Option (Right to Buy) | −500 | 2,152 | D | ||
| Open-market sales · 500 sh · avg $505.38 · $252,689 | |||||||
Loading xslF345X03/rdgdoc.xml…